Month: October 2022

On May 21, 2020, Ahadi, Somayeh; Awan, Shahid I.; Werz, Daniel B. published an article.Safety of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate The title of the article was Total Synthesis of Tri-, Hexa- and Heptasaccharidic Substructures of the O-Polysaccharide of Providencia rustigianii O34. And the article contained the following:

A general and efficient strategy for synthesis of tri-, hexa- and heptasaccharidic substructures of the lipopolysaccharide of Providencia rustigianii O34 is described. For the heptasaccharide seven different building blocks were employed. Special features of the structures are an α-linked galactosamine and the two embedded α-fucose units, which are either branched at positions-3 and -4 or further linked at their 2-position. Convergent strategies focused on [4+3], [3+4], and [4+2+1] coupling. Whereas the [4+3] and [3+4] coupling strategies failed the [4+2+1] strategy was successful. As monosaccharidic building blocks trichloroacetimidates and phosphates were employed. Global deprotection of the fully protected structures was achieved by Birch reaction. The experimental process involved the reaction of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate(cas: 2873-29-2).Safety of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

The Article related to synthon lipopolysaccharide providencia rustigianii oligosaccharide preparation galactosamine coupling, oligosaccharide aminoglycoside preparation providencia rustigianii polysaccharide coupling birch, providencia rustigianii, fucose, glycosylation, lipopolysaccharide (lps), oligosaccharides and other aspects.Safety of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On August 10, 2011, Hu, Mingyu; Li, Lin; Wu, Hao; Su, Ying; Yang, Peng-Yu; Uttamchandani, Mahesh; Xu, Qing-Hua; Yao, Shao Q. published an article.Formula: C12H15NO4 The title of the article was Multicolor, one- and two-photon imaging of enzymatic activities in live cells with fluorescently quenched activity-based probes (qABPs). And the article contained the following:

Fluorescence imaging provides an indispensable way to locate and monitor biol. targets within complex and dynamic intracellular environments. Of the various imaging agents currently available, small mol.-based probes provide a powerful tool for live cell imaging, primarily due to their desirable properties, including cell permeability (as a result of their smaller sizes), chem. tractability (e.g., different mol. structures/designs can be installed), and amenability to imaging a wide variety of biol. events. With a few exceptions, most existing small mol. probes are however not suitable for in vivo bioimaging experiments in which high-resolution studies of enzyme activity and localization are necessary. Here, the authors report a new class of fluorescently quenched activity-based probes (qABPs) which are highly modular, and can sensitively image (through multiple enzyme turnovers leading to fluorescence signal amplification) different types of enzyme activities in live mammalian cells with good spatial and temporal resolution The authors also incorporated 2-photon dyes into their modular probe design, enabling for the 1st time activity-based, fluorogenic 2-photon imaging of enzyme activities. Thus, this expands the repertoire of ‘smart’, responsive probes currently available for live cell bioimaging experiments The experimental process involved the reaction of tert-Butyl 2-(4-nitrophenyl)acetate(cas: 29704-38-9).Formula: C12H15NO4

The Article related to enzyme imaging live cell fluorescently quenched activity based probe, caspase imaging live cell fluorescently quenched activity based probe, phosphatase imaging live cell fluorescently quenched activity based probe, fluorescently quenched activity based probe preparation enzyme imaging cell and other aspects.Formula: C12H15NO4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On November 30, 2020, Fan, Shanshan; Tang, Ke; Xu, Yan; Chen, Shuang published an article.Application In Synthesis of Diethyl succinate The title of the article was Characterization of the potent odorants in Tibetan Qingke Jiu by sensory analysis, aroma extract dilution analysis, quantitative analysis and odor activity values. And the article contained the following:

Tibetan Qingke Jiu is the most important alc. beverage in the daily life of Tibetan people due to its unique flavor and rich nutrients. In this study, the aromatic characteristics of Qingke Jiu were studied by sensory anal., aroma extract dilution anal. (AEDA), quant. anal., and odor activity values (OAVs). Sensory evaluation demonstrated that Qingke Jiu had fruity, cooked potato, honey, sour, sweet, and caramel-like aroma. A total of 66 aroma compounds were identified by AEDA and gas chromatog.-mass spectrometry, with flavor dilution (FD) factors ranging from 4 to 2048. Among them, methional, acetic acid, Et butanoate, phenylacetaldehyde and U+03B2-phenylethanol appeared with the highest FD factors. The concentration of these aroma-active compounds was further quantitated by combination of four different quant. measurements, and 17 odorants had concentrations higher than their odor thresholds. Based on the OAVs, phenylacetaldehyde, U+03B2-phenylethanol, Et phenylacetate, sotolon, furaneol, methional, methionol, U+03B3-nonalactone, Et 2-methylbutanoate, U+03B2-damascenone, Et 3-methylbutanoate, Et acetate, Et butanoate, and acetic acid could be potentially important to the overall aroma profile of Qingke Jiu. The experimental process involved the reaction of Diethyl succinate(cas: 123-25-1).Application In Synthesis of Diethyl succinate

The Article related to tibetan qingke jiu sensory odorants, aeda, acetic acid, aroma active compounds, ethyl 2-methylbutanoate, ethyl 3-methylbutanoate, furaneol, methional, oavs, phenylacetaldehyde, quantitative analysis, sensory analysis, sotolon, tibetan qingke jiu, β-damascenone, β-phenylethanol, γ-nonalactone and other aspects.Application In Synthesis of Diethyl succinate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Senol, Ilbilge Merve; Celik, Ilhami; Avan, Ilker published an article in 2019, the title of the article was One-pot synthesis of quinazolin-4(3H)-ones and 2,3-dihydroquinazolin-4(1H)-ones utilizing N-(2-aminobenzoyl)benzotriazoles.Recommanded Product: 707-07-3 And the article contains the following content:

A convenient and efficient method has emerged for the one-pot synthesis of substituted quinazolin-4(3H)-ones and nonaromatic alkaloids. 2-Substituted quinazolin-4(3H)-ones, 2,3-disubstituted quinazolin-4(3H)-ones, and 2,3-dihydroquinazolin-4(1H)-ones were obtained at yields of 46% to 95% by a one-pot reaction of N-(2-aminobenzoyl)benzotriazoles with amines and orthoesters or aldehydes under catalyst-free conditions. The experimental process involved the reaction of (Trimethoxymethyl)benzene(cas: 707-07-3).Recommanded Product: 707-07-3

The Article related to aminobenzoyl benzotriazole orthoester ammonium acetate one pot reaction, quinazolinone preparation green chem, aldehyde aminobenzoyl benzotriazole ammonium acetate one pot reaction, primary amine aminobenzoyl benzotriazole aldehyde one pot reaction, dihydroquinazolinone preparation green chem and other aspects.Recommanded Product: 707-07-3

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On October 31, 2021, Reijneveld, Josephine F.; Marino, Laura; Cao, Thinh-Phat; Cheng, Tan-Yun; Dam, Dennis; Shahine, Adam; Witte, Martin D.; Filippov, Dmitri V.; Suliman, Sara; van der Marel, Gijsbert A.; Moody, D. Branch; Minnaard, Adriaan J.; Rossjohn, Jamie; Codee, Jeroen D. C.; Van Rhijn, Ildiko published an article.Reference of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate The title of the article was Rational design of a hydrolysis-resistant mycobacterial phosphoglycolipid antigen presented by CD1c to T cells. And the article contained the following:

Whereas proteolytic cleavage is crucial for peptide presentation by classical major histocompatibility complex (MHC) proteins to T cells, glycolipids presented by CD1 mols. are typically presented in an unmodified form. However, the mycobacterial lipid antigen mannosyl-β1-phosphomycoketide (MPM) may be processed through hydrolysis in antigen presenting cells, forming mannose and phosphomycoketide (PM). To further test the hypothesis that some lipid antigens are processed, and to generate antigens that lead to defined epitopes for future tuberculosis vaccines or diagnostic tests, we aimed to create hydrolysis-resistant MPM variants that retain their antigenicity. Here, we designed and tested three different, versatile synthetic strategies to chem. stabilize MPM analogs. Crystallog. studies of CD1c complexes with these three new MPM analogs showed anchoring of the lipid tail and phosphate group that is highly comparable to nature-identical MPM, with considerable conformational flexibility for the mannose head group. MPM-3, a difluoromethylene-modified version of MPM that is resistant to hydrolysis, showed altered recognition by cells, but not by CD1c proteins, supporting the cellular antigen processing hypothesis. Furthermore, the synthetic analogs elicited T cell responses that were cross-reactive with nature-identical MPM, fulfilling important requirements for future clin. use. The experimental process involved the reaction of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate(cas: 2873-29-2).Reference of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

The Article related to glycoside hydrolysis resistant mycobacterial glycophospholipid phosphoglycolipid antigen antibacterial, ifn interferon human cd1c antigen vaccine immunization glycophospholipid preparation, cd1c, t-cell receptor (tcr), antigen presentation, glycolipid, lipid synthesis, protein crystallization and other aspects.Reference of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On December 17, 2021, Ofman, Tim P.; Kuellmer, Florian; van der Marel, Gijsbert A.; Codee, Jeroen D. C.; Overkleeft, Herman S. published an article.Related Products of 2873-29-2 The title of the article was An Orthogonally Protected Cyclitol for the Construction of Nigerose- and Dextran-Mimetic Cyclophellitols. And the article contained the following:

Cyclophellitols are potent inhibitors of exo- and endoglycosidases. Efficient synthetic methodologies are needed to fully capitalize on this intriguing class of mechanism-based enzyme de-activators. We report the synthesis of an orthogonally protected cyclitol from D-glucal (19% yield over 12 steps) and its use in the synthesis of α-(1,3)-linked di- and trisaccharide dextran mimetics. These new glycomimetics may find use as Dextranase inhibitors, and the developed chemistries in widening the palette of glyco-processing enzyme-targeting glycomimetics. The experimental process involved the reaction of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate(cas: 2873-29-2).Related Products of 2873-29-2

The Article related to epoxidation aziridination trisaccharide dextran mimetic cyclitol nigerose cyclophellitol, oligosaccharide trisaccharide dextran cyclophellitol preparation endoglycosidase inhibitor aziridine, trisaccharide dextran cyclophellitol endoglycosidase glycomimetic dextranase inhibitor glucal cyclitol and other aspects.Related Products of 2873-29-2

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On September 23, 1999, Buchanan, John; Bohacek, Regine; Vu, Chi B.; Luke, George P. published a patent.Name: (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate The title of the patent was Preparation of heterocyclyl phosphotyrosine derivatives as SH2-mediated signal transduction inhibitors. And the patent contained the following:

Heterocyclic phosphotyrosine derivatives were prepared for inhibiting intracellular signal transduction, especially intracellular signal transduction mediated by a PDGF receptor protein, EGF receptor protein, HER2/Neu receptor protein, fibroblast growth factor receptor protein, focal adhesion kinase protein, p130 protein, or p68 protein. For example, BOC-Tyr(PO3Bn2)-OH (BOC = tert-butoxycarbonyl; Bn = benzyl) and the thiazolylamine salt (I)·TFA (four step preparation given) were coupled, the phosphate deprotected, the amine acylated, and the carboxylic acid deprotected to form the title compound (II). In an assay for binding affinities to Src SH2, thirteen compounds of the invention were determined to have IC50 values of < 50μM. In an assay for binding affinities to Zap-70 SH2, fourteen compounds of the invention exhibited IC50 values of < 50μM. This invention also relates to pharmaceutical compositions containing the compounds and prophylactic and therapeutic methods involving pharmaceutical and veterinary administration of the compounds for proliferative disease, cancer, restenosis, osteoporosis, inflammation, allergies, cardiovascular disease, or immunosuppression. The experimental process involved the reaction of (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate(cas: 53838-27-0).Name: (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate

The Article related to peptide heterocyclyl phosphotyrosine preparation signal transduction inhibitor, antitumor heterocyclyl phosphotyrosine preparation antiosteoporotic antiinflammatory antiallergenic immunosuppressant, tyrosine phospho heterocyclyl preparation proliferative disease cardiovascular disease treatment and other aspects.Name: (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Teixeira, Priscila Camillo; Ducret, Axel; Langen, Hanno; Nogoceke, Everson; Santos, Ronaldo Honorato Barros; Nunes, Joao Paulo Silva; Benvenuti, Luiz; Levy, Debora; Bydlowski, Sergio Paulo; Bocchi, Edimar Alcides; Takara, Andreia Kuramoto; Fiorelli, Alfredo Inacio; Stolf, Noedir Antonio; Pomeranzeff, Pablo; Chevillard, Christophe; Kalil, Jorge; Cunha-Neto, Edecio published an article in 2021, the title of the article was Impairment of multiple mitochondrial energy metabolism pathways in the heart of chagas disease cardiomyopathy patients.Category: esters-buliding-blocks And the article contains the following content:

Chagas disease cardiomyopathy (CCC) is an inflammatory dilated cardiomyopathy occurring in 30% of the 6 million infected with the protozoan Trypanosoma cruzi in Latin America. Survival is significantly lower in CCC than ischemic (IC) and idiopathic dilated cardiomyopathy (DCM). Previous studies disclosed a selective decrease in mitochondrial ATP synthase alpha expression and creatine kinase activity in CCC myocardium as compared to IDC and IC, as well as decreased in vivo myocardial ATP production Aiming to identify addnl. constraints in energy metabolism specific to CCC, we performed a proteomic study in myocardial tissue samples from CCC, IC and DCM obtained at transplantation, in comparison with control myocardial tissue samples from organ donors. Left ventricle free wall myocardial samples were subject to two-dimensional electrophoresis with fluorescent labeling (2D-DIGE) and protein identification by mass spectrometry. We found altered expression of proteins related to mitochondrial energy metabolism, cardiac remodeling, and oxidative stress in the 3 patient groups. Pathways anal. of proteins differentially expressed in CCC disclosed mitochondrial dysfunction, fatty acid metabolism and transmembrane potential of mitochondria. CCC patients’ myocardium displayed reduced expression of 22 mitochondrial proteins belonging to energy metabolism pathways, as compared to 17 in DCM and 3 in IC. Significantly, 6 beta-oxidation enzymes were reduced in CCC, while only 2 of them were down-regulated in DCM and 1 in IC. We also observed that the cytokine IFN-gamma, previously described with increased levels in CCC, reduces mitochondrial membrane potential in cardiomyocytes. Results suggest a major reduction of mitochondrial energy metabolism and mitochondrial dysfunction in CCC myocardium which may be in part linked to IFN-gamma. This may partially explain the worse prognosis of CCC as compared to DCM or IC. The experimental process involved the reaction of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)(cas: 2358-84-1).Category: esters-buliding-blocks

The Article related to mitochondrial energy metabolism pathway chagas disease cardiomyopathy human, chronic chagas disease cardiomyopathy, energy metabolism, idiopathic dilated cardiomyopathy, interferon-gamma, ischemic cardiomyopathy, mitochondria, proteomics, two-dimensional electrophoresis with fluorescent labeling and other aspects.Category: esters-buliding-blocks

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On April 2, 1999, Akazome, Motohiro; Takahashi, Toshiaki; Ogura, Katsuyuki published an article.Formula: C7H14O3 The title of the article was Enantiomeric Inclusion of α-Hydroxy Esters by (R)-(1-Naphthyl)glycyl-(R)-phenylglycine and the Crystal Structures of the Inclusion Cavities. And the article contained the following:

A simple dipeptide, (R)-(1-naphthyl)glycyl-(R)-phenylglycine [(R,R)-I], formed inclusion compounds with several α-hydroxy esters with high enantioselectivity. By crystallization of a mixture of the dipeptide I and racemic MeCH(OH)CO2Me [(RS)-II] from methanol, asym. recognition occurred to give an inclusion compound that contains S-II in 89% ee. X-ray crystallog. study of the inclusion compound elucidated that the dipeptide mols. arrange in a “folded antiparallel” β-sheetlike structure to accommodate the α-hydroxy ester in the pocket-type cavity surrounded by naphthyl and Ph groups on the sheet. Similarly, MeCH(OH)CO2Et and dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanone were included with high enantioselectivity of the S form. When bulkier Me3CCH(OH)CO2Me was used as a guest mol., the arrangement of dipeptide mols. changed to an “extended antiparallel” mode, where the naphthyl and Ph groups arranged in a “parallel stacked and displaced” mode and a channel-type cavity was constructed. The guest mols. were accommodated via hydrogen bonding in the channel-type cavity with high enantioselectivity of the S form (82% ee). In the case of Me2CHCH(OH)CO2Me [(RS)-III], optically pure (S)-III formed the dipeptide sheet with the “folded antiparallel” structure by cocrystn. with I, while the “extended antiparallel” structure appeared in the inclusion of (RS)-III. The experimental process involved the reaction of Methyl 2-hydroxy-3,3-dimethylbutanoate(cas: 121129-31-5).Formula: C7H14O3

The Article related to enantioselective inclusion hydroxy ester naphthylglycylphenylglycine, stereoselective crystallization hydroxy ester naphthylglycylphenylglycine, crystal structure hydroxy ester naphthylglycylphenylglycine inclusion complex, hydrogen bond hydroxy ester naphthylglycylphenylglycine inclusion complex and other aspects.Formula: C7H14O3

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On November 12, 2009, Rogers, Kathryn; Patzke, Holger published a patent.Reference of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate The title of the patent was Preparation of benzo-fused 7-membered heterocyclic compounds and methods for treating cognitive disorders using inhibitors of histone deacetylase. And the patent contained the following:

This disclosure relates to compounds for the inhibition of histone deacetylase and treatment of a cognitive disorder or deficit, more specifically neurodegenerative disease, polyglutamine disease, tauopathy, Alzheimer’s Disease, or Huntington’s Disease. More particularly, the disclosure provides for compounds of formula [I; Z = H, (un)substituted NHOH; L = a covalent bond, (un)substituted N(OH); when L = (un)substituted N(OH), Z = H; when Z = H, L = (un)substituted N(OH); J = a covalent bond, :CH, -C1-8 alkyl-, -C0-3 alkyl-C1-5 heteroalkyl-C0-3 alkyl-, -C0-3 alkyl-C2-5 alkenyl-C0-3 alkyl-, -C0-3 alkyl-C2-5 alkynyl-C0-3 alkyl-, -C0-6 alkylaryl-C0-6 alkyl-, -C0-6 alkylaryl-C2-6 heteroalkyl-, etc.; Q = heterocycle-containing group, a covalent bond, -C1-8 alkyl-, -C1-5 alkyl-, -C1-5 heterocyclyl-, ;N-O-, N-(un)substituted -C0-6 alkyl-NH-C0-3 alkyl-, -C0-6 alkyl-O-C0-3 alkyl-, etc.; ring B = 7-membered fused heterocycle group, etc.] or a pharmaceutically acceptable salts thereof. Thus, to a solution of (E)-1-chlorodibenzo[b,f][1,4]oxazepine (229 mg, 1.00 mmol) in DME (3 mL) was added 4-methoxycarbonylphenylboronic acid (216 mg), Pd(PPh3)4 (0.065 mg) and 2 N Na2CO3 (aqueous) (1.5 mL). The reaction mixture was stirred for 2 h at 90° to give, after workup and silica gel chromatog., (Z)-Me 4-(dibenzo[b,f][1,4]oxazepin-1-yl)benzoate (II) (327 mg, 99%) as a yellow foam. To a stirring solution of ester II (327 mg) in MeOH (4.0 mL) and THF (4.0 mL) was added 50% hydroxylamine (aqueous) (1.2 mL, excess) followed by KOH (212 mg) and the reaction mixture was stirred at room temperature for 15 min to give, after workup and silica gel chromatog., (Z)-4-(dibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide (III). III showed IC50 of ≤0.05 μM against histone deacetylase and also IC50 of ≤1 μM for whole-cell histone deacetylase (HDAC) Inhibition assay in primary mouse cortical cultures. The experimental process involved the reaction of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate(cas: 227940-70-7).Reference of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

The Article related to benzo fused 7 membered heterocycle preparation histone deacetylase inhibitor, neurodegenerative disease polyglutamine disease treatment heterocycle preparation, tauopathy alzheimer disease huntington disease treatment heterocycle preparation, dibenzooxazepine benzopyridooxazepine dibenzothiazepine and other aspects.Reference of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics